colored cancer cells

Visualizing the Future: Spacialomics Transforms Study of Gene Expression

Gene editing

Home » Emerging technologies » Gene editing » Page 2

mushroom

Intellia Therapeutics Receives Grant to Develop Curative CRISPR/Cas9 In Vivo Sickle Cell Disease Treatments

Intellia Therapeutics

Intellia Therapeutics Doses First Patient in Landmark CRISPR/Cas9 Clinical Trial of NTLA-2001 for the Treatment of Transthyretin Amyloidosis

These CRISPR Edited Seeds Are Planting A Sustainable Future For The Agricultural Industry

Recombia Biosciences

Lesaffre and Recombia Biosciences to advance innovative gene editing technology through a strategic partnership

Sri Kosaraju

Inscripta Appoints Sri Kosaraju as President and CEO

mushroom

Synthego’s CRISPR Platform Enables Faster Identification of Potential Coronavirus Treatment

mushroom

Synthego Pioneers Next-Generation CRISPR Light Control Technology

mushroom

Scribe Therapeutics to Collaborate With Biogen to Develop CRISPR-based Genetic Medicines for Neurological Diseases, Including Amyotrophic Lateral Sclerosis

mushroom

Scribe Therapeutics Unveils Fully Integrated Platform for Engineering Breakthrough CRISPR-based Genetic Medicines

mushroom

Novome Biotechnologies Expands Therapeutic Focus and Platform Capabilities with Acquisition of Preclinical Projects and Intellectual Property from Caribou Biosciences and License to CRISPR-Cas9 Foundational Patent Portfolio